Age-Specific Incidence of Melanoma in the United States
Melanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the United States, but the effect on melanoma incidence is unknown. To examine the incidence of melanoma in the United States and whether any age-spe...
Gespeichert in:
| Veröffentlicht in: | JAMA dermatology (Chicago, Ill.) Jg. 156; H. 1; S. 57 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.01.2020
|
| Schlagworte: | |
| ISSN: | 2168-6084, 2168-6084 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Melanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the United States, but the effect on melanoma incidence is unknown.
To examine the incidence of melanoma in the United States and whether any age-specific differences are present.
Observational, population-based registry data were extracted on July 3, 2018, from the combined National Program of Cancer Registries-Surveillance Epidemiology and End Results United States Cancer Statistics database for 2001-2015. Deidentified data for 988 103 cases of invasive melanoma, with International Classification of Diseases for Oncology histologic categorization codes 8720 to 8790, were used for analysis. Data analysis was performed from July 1, 2018, to March 1, 2019.
The annual rates of melanoma in pediatric, adolescent, young adult, and adult age groups were determined. Analyses were stratified by sex, and incidence rates were age-adjusted to the 2000 US standard population. Annual percentage change (APC) in incidence rate was calculated over the most recent decade for which data were available (2006-2015) using the weighted least squares method.
In 2015, 83 362 cases of invasive melanoma were reported in the United States, including 67 in children younger than 10 years, 251 in adolescents (10-19 years), and 1973 in young adults (20-29 years). Between 2006 and 2015, the overall incidence rate increased from 200.1 to 229.1 cases per million person-years. In adults aged 40 years or older, melanoma rates increased by an APC of 1.8% in both men (95% CI, 1.4%-2.1%) and women (95% CI, 1.4%-2.2%). In contrast, clinically and statistically significant decreases were seen in melanoma incidence for adolescents and young adults. Specifically, incidence rates decreased by an APC of -4.4% for male adolescents (95% CI, -1.7% to -7.0%), -5.4% for female adolescents (95% CI, -3.3% to -7.4%), -3.7% for male young adults (95% CI, -2.5% to -4.8%), and -3.6% for female young adults (95% CI, -2.8% to -4.5%). Data on skin pigmentation and sun protection history were unavailable; similar trends were observed with data limited to non-Hispanic whites. Young adult women appeared to have twice the risk of melanoma as young adult men.
The incidence of invasive melanoma in the United States appeared to decrease in adolescents and young adults from 2006 to 2015, and this finding contrasted with increases in older populations. These incidence trends suggest that public health efforts may be favorably influencing melanoma incidence in the United States. |
|---|---|
| AbstractList | Melanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the United States, but the effect on melanoma incidence is unknown.
To examine the incidence of melanoma in the United States and whether any age-specific differences are present.
Observational, population-based registry data were extracted on July 3, 2018, from the combined National Program of Cancer Registries-Surveillance Epidemiology and End Results United States Cancer Statistics database for 2001-2015. Deidentified data for 988 103 cases of invasive melanoma, with International Classification of Diseases for Oncology histologic categorization codes 8720 to 8790, were used for analysis. Data analysis was performed from July 1, 2018, to March 1, 2019.
The annual rates of melanoma in pediatric, adolescent, young adult, and adult age groups were determined. Analyses were stratified by sex, and incidence rates were age-adjusted to the 2000 US standard population. Annual percentage change (APC) in incidence rate was calculated over the most recent decade for which data were available (2006-2015) using the weighted least squares method.
In 2015, 83 362 cases of invasive melanoma were reported in the United States, including 67 in children younger than 10 years, 251 in adolescents (10-19 years), and 1973 in young adults (20-29 years). Between 2006 and 2015, the overall incidence rate increased from 200.1 to 229.1 cases per million person-years. In adults aged 40 years or older, melanoma rates increased by an APC of 1.8% in both men (95% CI, 1.4%-2.1%) and women (95% CI, 1.4%-2.2%). In contrast, clinically and statistically significant decreases were seen in melanoma incidence for adolescents and young adults. Specifically, incidence rates decreased by an APC of -4.4% for male adolescents (95% CI, -1.7% to -7.0%), -5.4% for female adolescents (95% CI, -3.3% to -7.4%), -3.7% for male young adults (95% CI, -2.5% to -4.8%), and -3.6% for female young adults (95% CI, -2.8% to -4.5%). Data on skin pigmentation and sun protection history were unavailable; similar trends were observed with data limited to non-Hispanic whites. Young adult women appeared to have twice the risk of melanoma as young adult men.
The incidence of invasive melanoma in the United States appeared to decrease in adolescents and young adults from 2006 to 2015, and this finding contrasted with increases in older populations. These incidence trends suggest that public health efforts may be favorably influencing melanoma incidence in the United States. Melanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the United States, but the effect on melanoma incidence is unknown.ImportanceMelanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the United States, but the effect on melanoma incidence is unknown.To examine the incidence of melanoma in the United States and whether any age-specific differences are present.ObjectiveTo examine the incidence of melanoma in the United States and whether any age-specific differences are present.Observational, population-based registry data were extracted on July 3, 2018, from the combined National Program of Cancer Registries-Surveillance Epidemiology and End Results United States Cancer Statistics database for 2001-2015. Deidentified data for 988 103 cases of invasive melanoma, with International Classification of Diseases for Oncology histologic categorization codes 8720 to 8790, were used for analysis. Data analysis was performed from July 1, 2018, to March 1, 2019.Design, Setting, and ParticipantsObservational, population-based registry data were extracted on July 3, 2018, from the combined National Program of Cancer Registries-Surveillance Epidemiology and End Results United States Cancer Statistics database for 2001-2015. Deidentified data for 988 103 cases of invasive melanoma, with International Classification of Diseases for Oncology histologic categorization codes 8720 to 8790, were used for analysis. Data analysis was performed from July 1, 2018, to March 1, 2019.The annual rates of melanoma in pediatric, adolescent, young adult, and adult age groups were determined. Analyses were stratified by sex, and incidence rates were age-adjusted to the 2000 US standard population. Annual percentage change (APC) in incidence rate was calculated over the most recent decade for which data were available (2006-2015) using the weighted least squares method.Main Outcomes and MeasuresThe annual rates of melanoma in pediatric, adolescent, young adult, and adult age groups were determined. Analyses were stratified by sex, and incidence rates were age-adjusted to the 2000 US standard population. Annual percentage change (APC) in incidence rate was calculated over the most recent decade for which data were available (2006-2015) using the weighted least squares method.In 2015, 83 362 cases of invasive melanoma were reported in the United States, including 67 in children younger than 10 years, 251 in adolescents (10-19 years), and 1973 in young adults (20-29 years). Between 2006 and 2015, the overall incidence rate increased from 200.1 to 229.1 cases per million person-years. In adults aged 40 years or older, melanoma rates increased by an APC of 1.8% in both men (95% CI, 1.4%-2.1%) and women (95% CI, 1.4%-2.2%). In contrast, clinically and statistically significant decreases were seen in melanoma incidence for adolescents and young adults. Specifically, incidence rates decreased by an APC of -4.4% for male adolescents (95% CI, -1.7% to -7.0%), -5.4% for female adolescents (95% CI, -3.3% to -7.4%), -3.7% for male young adults (95% CI, -2.5% to -4.8%), and -3.6% for female young adults (95% CI, -2.8% to -4.5%). Data on skin pigmentation and sun protection history were unavailable; similar trends were observed with data limited to non-Hispanic whites. Young adult women appeared to have twice the risk of melanoma as young adult men.ResultsIn 2015, 83 362 cases of invasive melanoma were reported in the United States, including 67 in children younger than 10 years, 251 in adolescents (10-19 years), and 1973 in young adults (20-29 years). Between 2006 and 2015, the overall incidence rate increased from 200.1 to 229.1 cases per million person-years. In adults aged 40 years or older, melanoma rates increased by an APC of 1.8% in both men (95% CI, 1.4%-2.1%) and women (95% CI, 1.4%-2.2%). In contrast, clinically and statistically significant decreases were seen in melanoma incidence for adolescents and young adults. Specifically, incidence rates decreased by an APC of -4.4% for male adolescents (95% CI, -1.7% to -7.0%), -5.4% for female adolescents (95% CI, -3.3% to -7.4%), -3.7% for male young adults (95% CI, -2.5% to -4.8%), and -3.6% for female young adults (95% CI, -2.8% to -4.5%). Data on skin pigmentation and sun protection history were unavailable; similar trends were observed with data limited to non-Hispanic whites. Young adult women appeared to have twice the risk of melanoma as young adult men.The incidence of invasive melanoma in the United States appeared to decrease in adolescents and young adults from 2006 to 2015, and this finding contrasted with increases in older populations. These incidence trends suggest that public health efforts may be favorably influencing melanoma incidence in the United States.Conclusions and RelevanceThe incidence of invasive melanoma in the United States appeared to decrease in adolescents and young adults from 2006 to 2015, and this finding contrasted with increases in older populations. These incidence trends suggest that public health efforts may be favorably influencing melanoma incidence in the United States. |
| Author | Wojcik, Katherine Thompson, John A Paulson, Kelly G Byrd, David R Chapuis, Aude G Madeleine, Margaret M Bhatia, Shailender Veatch, Joshua R Gupta, Deepti Kim, Teresa S Gardner, Jennifer M |
| Author_xml | – sequence: 1 givenname: Kelly G surname: Paulson fullname: Paulson, Kelly G organization: Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington – sequence: 2 givenname: Deepti surname: Gupta fullname: Gupta, Deepti organization: Department of Pediatrics, University of Washington, Seattle – sequence: 3 givenname: Teresa S surname: Kim fullname: Kim, Teresa S organization: Department of Surgery, University of Washington, Seattle – sequence: 4 givenname: Joshua R surname: Veatch fullname: Veatch, Joshua R organization: Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington – sequence: 5 givenname: David R surname: Byrd fullname: Byrd, David R organization: Department of Surgery, University of Washington, Seattle – sequence: 6 givenname: Shailender surname: Bhatia fullname: Bhatia, Shailender organization: Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington – sequence: 7 givenname: Katherine surname: Wojcik fullname: Wojcik, Katherine organization: Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington – sequence: 8 givenname: Aude G surname: Chapuis fullname: Chapuis, Aude G organization: Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington – sequence: 9 givenname: John A surname: Thompson fullname: Thompson, John A organization: Melanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington – sequence: 10 givenname: Margaret M surname: Madeleine fullname: Madeleine, Margaret M organization: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington – sequence: 11 givenname: Jennifer M surname: Gardner fullname: Gardner, Jennifer M organization: Division of Dermatology, University of Washington, Seattle |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31721989$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNTztPwzAYtFARLaV_ofLIkuJX_BirikelIobSOXLsz5AqcUrsDvx7IlEkbrkbTve4RZPYR0BoScmKEkIfjrazHobO5r5dMULNivOSX6EZo1IXkmgx-aenaJHSkYzQhAhOb9CUU8Wo0WaG1PoDiv0JXBMah7fRNR6iA9wH_AqtjX1ncRNx_gR8iE0Gj_fZZkh36DrYNsHiwnN0eHp837wUu7fn7Wa9K6yQNBeMU00U8FCLmmjptRQCal8Gx3VQ3oH0IYQSTE2tdJIZV2utlAEpqARv2Bzd_-aehv7rDClXXZMctOM06M-pGgtEKUtF2WhdXqznugNfnYams8N39XeW_QBB5Vr0 |
| CitedBy_id | crossref_primary_10_1053_j_semdp_2020_09_001 crossref_primary_10_1016_j_jid_2024_05_032 crossref_primary_10_1111_ddg_15281_g crossref_primary_10_1111_jdv_20344 crossref_primary_10_1200_JCO_24_01519 crossref_primary_10_1001_jamadermatol_2024_5129 crossref_primary_10_1016_j_clindermatol_2025_01_013 crossref_primary_10_1111_bjd_19499 crossref_primary_10_1016_j_clindermatol_2025_01_010 crossref_primary_10_7759_cureus_19117 crossref_primary_10_1001_jamanetworkopen_2022_3461 crossref_primary_10_1016_j_ejca_2024_114305 crossref_primary_10_1016_j_xcrm_2025_102283 crossref_primary_10_1016_j_canep_2023_102515 crossref_primary_10_1097_JW9_0000000000000199 crossref_primary_10_1016_j_pharmthera_2024_108698 crossref_primary_10_1016_j_jaad_2021_01_097 crossref_primary_10_3390_cancers17152597 crossref_primary_10_1038_s41598_025_85670_3 crossref_primary_10_1007_s12094_021_02644_3 crossref_primary_10_1001_jamadermatol_2024_3514 crossref_primary_10_3389_fpubh_2024_1486617 crossref_primary_10_1080_08941939_2024_2401125 crossref_primary_10_1089_jayao_2021_0180 crossref_primary_10_3390_ijms26135985 crossref_primary_10_1038_s41419_025_07337_1 crossref_primary_10_1007_s00403_024_03077_y crossref_primary_10_1002_ski2_27 crossref_primary_10_1016_j_canep_2021_101932 crossref_primary_10_3390_ijms23063094 crossref_primary_10_1093_occmed_kqae069 crossref_primary_10_3389_fonc_2022_868004 crossref_primary_10_1245_s10434_021_10273_x crossref_primary_10_3390_cells12020294 crossref_primary_10_1001_jamadermatol_2025_1276 crossref_primary_10_3390_cancers13174367 crossref_primary_10_1016_j_ypmed_2023_107692 crossref_primary_10_1007_s11912_024_01542_5 crossref_primary_10_1016_j_suc_2024_12_003 crossref_primary_10_1111_cbdd_14418 crossref_primary_10_1016_j_ejphar_2020_173593 crossref_primary_10_1111_pcmr_70017 crossref_primary_10_3390_dermatopathology9040043 crossref_primary_10_7759_cureus_79703 crossref_primary_10_1016_j_jaad_2023_05_030 crossref_primary_10_1111_risa_14152 crossref_primary_10_1016_j_bioactmat_2023_03_016 crossref_primary_10_1007_s11912_022_01306_z crossref_primary_10_1016_j_neo_2021_11_013 crossref_primary_10_1245_s10434_024_15573_6 crossref_primary_10_3389_fimmu_2023_1178776 crossref_primary_10_1245_s10434_022_11547_8 crossref_primary_10_1002_cam4_3545 crossref_primary_10_1136_bmjebm_2023_112341 crossref_primary_10_1016_j_ejca_2020_10_026 crossref_primary_10_1016_j_jaci_2020_11_023 crossref_primary_10_1016_j_jaad_2024_10_084 crossref_primary_10_1097_WNO_0000000000001399 crossref_primary_10_3390_cancers16061167 crossref_primary_10_3390_cancers17172920 crossref_primary_10_1007_s12262_020_02374_w crossref_primary_10_3390_diagnostics15030260 crossref_primary_10_1097_CMR_0000000000000817 crossref_primary_10_1001_jamadermatol_2022_0160 crossref_primary_10_1080_09603123_2021_1977257 crossref_primary_10_1158_1940_6207_CAPR_21_0244 crossref_primary_10_3390_cancers14122873 crossref_primary_10_3390_a15120443 crossref_primary_10_3390_cancers15164125 crossref_primary_10_1093_ced_llae466 crossref_primary_10_1093_jnci_djad115 crossref_primary_10_1097_CM9_0000000000003416 crossref_primary_10_1136_jitc_2023_006947 crossref_primary_10_1007_s11302_021_09821_7 crossref_primary_10_3390_cancers14071752 crossref_primary_10_1016_j_jid_2021_12_031 crossref_primary_10_1007_s43630_020_00001_x crossref_primary_10_1016_j_jdermsci_2022_02_003 crossref_primary_10_1002_cncr_34479 crossref_primary_10_3390_ijerph18084165 crossref_primary_10_2196_67902 crossref_primary_10_3390_life13010181 crossref_primary_10_1016_j_jaad_2023_04_008 crossref_primary_10_1093_jnci_djac138 crossref_primary_10_1080_07853890_2022_2026001 crossref_primary_10_1002_ijc_33259 crossref_primary_10_5826_dpc_1502a5219 crossref_primary_10_1016_j_jid_2022_08_058 crossref_primary_10_1080_17460441_2020_1795124 crossref_primary_10_1097_OGX_0000000000001154 crossref_primary_10_1177_12034754251335590 crossref_primary_10_3390_cancers13061455 crossref_primary_10_1001_jamadermatol_2021_1850 crossref_primary_10_1097_IOP_0000000000002895 crossref_primary_10_1186_s12877_024_04806_8 crossref_primary_10_1097_CMR_0000000000001000 crossref_primary_10_3389_fonc_2020_612459 crossref_primary_10_1080_14712598_2025_2484305 crossref_primary_10_1093_mtomcs_mfab074 crossref_primary_10_1038_s41698_025_00826_8 crossref_primary_10_1097_JDN_0000000000000719 crossref_primary_10_1080_08998280_2024_2439771 crossref_primary_10_3390_cancers13092090 crossref_primary_10_1007_s11764_024_01727_8 crossref_primary_10_3390_cancers17010061 crossref_primary_10_1093_joc_jqae029 crossref_primary_10_1002_cncr_33499 crossref_primary_10_3390_cancers16234014 crossref_primary_10_1002_lio2_1171 crossref_primary_10_1016_j_ejca_2021_09_044 crossref_primary_10_2217_fon_2020_0265 crossref_primary_10_1016_j_jaad_2023_11_070 crossref_primary_10_1016_j_jid_2024_05_011 crossref_primary_10_1097_CEJ_0000000000000716 crossref_primary_10_3390_life13040974 crossref_primary_10_1016_j_jid_2025_07_028 crossref_primary_10_1111_jdv_17879 crossref_primary_10_3390_cancers16152696 crossref_primary_10_1016_j_jaad_2022_10_063 crossref_primary_10_1093_jnci_djab077 crossref_primary_10_1007_s10552_022_01644_0 crossref_primary_10_1016_j_cson_2025_100095 crossref_primary_10_1002_cam4_3299 crossref_primary_10_3390_biomedicines9070758 crossref_primary_10_1155_2020_4858636 crossref_primary_10_3390_cancers13112838 crossref_primary_10_1093_clinchem_hvad202 crossref_primary_10_1111_jdv_17189 crossref_primary_10_1016_j_ejca_2024_115079 crossref_primary_10_1016_j_nbt_2023_04_006 crossref_primary_10_1016_j_jaad_2022_08_067 crossref_primary_10_1016_j_jid_2025_06_1594 crossref_primary_10_1016_j_pdpdt_2025_104528 crossref_primary_10_1172_JCI143763 crossref_primary_10_1245_s10434_024_15684_0 crossref_primary_10_1089_jwh_2021_0223 crossref_primary_10_1111_ddg_15281 crossref_primary_10_1111_pde_14516 crossref_primary_10_1002_der2_153 crossref_primary_10_1001_jamanetworkopen_2022_45269 crossref_primary_10_1097_DSS_0000000000003430 crossref_primary_10_1111_pcmr_13065 crossref_primary_10_1177_30502225251370801 crossref_primary_10_1016_j_jdin_2024_04_010 crossref_primary_10_3390_cancers17040707 crossref_primary_10_1016_j_canep_2025_102848 crossref_primary_10_1245_s10434_020_08312_0 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1001/jamadermatol.2019.3353 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2168-6084 |
| ExternalDocumentID | 31721989 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Observational Study Research Support, N.I.H., Extramural |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: T32 CA092408 – fundername: NCI NIH HHS grantid: T32 CA009515 – fundername: NCI NIH HHS grantid: P30 CA015704 – fundername: NCI NIH HHS grantid: T32 CA009168 |
| GroupedDBID | 0R~ 4.4 53G AAWTL ABJNI ACGFS ADBBV AENEX AFOSN AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BCGUY BRYMA C45 CGR CUY CVF EBD EBS ECM EIF EMOBN EX3 NPM OB3 OBH OGROG OHH OVD PQQKQ RAJ SV3 TEORI WOW 7X8 |
| ID | FETCH-LOGICAL-a461t-231807e3fb4b086d8644ebd5fc38f7dce6dfff5e9b1a6c629cb88779e6416ed92 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 170 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000506614500007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2168-6084 |
| IngestDate | Thu Oct 02 09:06:39 EDT 2025 Thu Jan 02 22:57:59 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a461t-231807e3fb4b086d8644ebd5fc38f7dce6dfff5e9b1a6c629cb88779e6416ed92 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://jamanetwork.com/journals/jamadermatology/articlepdf/2754716/jamadermatology_paulson_2019_oi_190058.pdf |
| PMID | 31721989 |
| PQID | 2314565712 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2314565712 pubmed_primary_31721989 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-01-01 |
| PublicationDateYYYYMMDD | 2020-01-01 |
| PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAMA dermatology (Chicago, Ill.) |
| PublicationTitleAlternate | JAMA Dermatol |
| PublicationYear | 2020 |
| SSID | ssj0000800431 |
| Score | 2.6410694 |
| Snippet | Melanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 57 |
| SubjectTerms | Adolescent Adult Age Distribution Age Factors Aged Aged, 80 and over Child Child, Preschool Female Humans Incidence Infant Infant, Newborn Male Melanoma - epidemiology Middle Aged Risk Factors SEER Program - statistics & numerical data Sex Factors Skin Neoplasms - epidemiology United States - epidemiology Young Adult |
| Title | Age-Specific Incidence of Melanoma in the United States |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31721989 https://www.proquest.com/docview/2314565712 |
| Volume | 156 |
| WOSCitedRecordID | wos000506614500007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3LS8QwEMaDuiJefD_WFxG8RpukbZKTLOLiZZc9KOytpHlIQdvVXf37naRdPQmCl94KYTr98puZNh9CV_BUuVNJQhTsrlCg6IxowRVJPDOOUiGtt9FsQozHcjpVk67hNu8-q1xqYhRq25jQI78BDokjOspuZ28kuEaF6WpnobGKehxQJmS1mMrvHkugoTRaEjKaS5InMl3-JNwdPGSD_C2aMIOg6prz4JH8G2nGHWe4_d-17qCtjjXxoE2OXbTi6j20Meqm6ftIDJ4diQb0vjIYlKI1GMWNxyP3ouvmVeOqxoCIuEVT3KLpAXoa3j_ePZDOSIHoNKcLAuuRiXDcl2kJJYyVAEGutJk3XHphjcut9z5zqqQ6NzlTpgTtEcrlgGvOKnaI1uqmdscIW6EF046mHriRpqUsVaaFB7DQzKba9NHlMiQFJGqYPujaNR_z4icofXTUxrWYtSdqFDwUokqqkz_cfYo2Wah5YxvkDPU8vKbuHK2bz0U1f7-IGQDX8WT0BblQuYQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age-Specific+Incidence+of+Melanoma+in+the+United+States&rft.jtitle=JAMA+dermatology+%28Chicago%2C+Ill.%29&rft.au=Paulson%2C+Kelly+G&rft.au=Gupta%2C+Deepti&rft.au=Kim%2C+Teresa+S&rft.au=Veatch%2C+Joshua+R&rft.date=2020-01-01&rft.issn=2168-6084&rft.eissn=2168-6084&rft.volume=156&rft.issue=1&rft.spage=57&rft_id=info:doi/10.1001%2Fjamadermatol.2019.3353&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-6084&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-6084&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-6084&client=summon |